Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Susan Tate

    TitleAssociate Clinical Professor -
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address9500 Gilman Drive #0737
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview

      Biography

      My clinical and research interests focus on substance use disorders, co-occurring mental and physical health problems, and development and evaluation of clinical interventions for substance use disorders and improving health behaviors. I have been Principal Investigator and Co-Investigator on VA Merit Awards evaluating psychotherapy interventions for depression, posttraumatic stress disorder, and alcohol/substance use disorders. I provide mental and behavioral health services in Primary Care-Mental Health Integration in the VA San Diego Healthcare System.


      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cui R, Haller M, Skidmore JR, Goldsteinholm K, Norman S, Tate S. Treatment Attendance Among Veterans With Depression, Substance Use Disorder, and Trauma. J Dual Diagn. 2016 Jan-Mar; 12(1):15-26. PMID: 26828770.
        View in: PubMed
      2. Haller M, Norman SB, Cummins K, Trim RS, Xu X, Cui R, Allard CB, Brown SA, Tate S. Integrated Cognitive Behavioral Therapy Versus Cognitive Processing Therapy for Adults With Depression, Substance Use Disorder, and Trauma. J Subst Abuse Treat. 2016 Mar; 62:38-48. PMID: 26718130.
        View in: PubMed
      3. Worley MJ, Trim RS, Tate S, Roesch SC, Myers MG, Brown SA. Self-efficacy and social networks after treatment for alcohol or drug dependence and major depression: Disentangling person and time-level effects. Psychol Addict Behav. 2014 Dec; 28(4):1220-9. PMID: 25347018.
        View in: PubMed
      4. Cui R, Tate S, Cummins K, Skidmore JR, Brown SA. Chronic physical health problems moderate changes in depression and substance use among dual diagnosed individuals during and after treatment. Subst Use Misuse. 2015 Jan 28; 50(2):174-83. PMID: 25290658.
        View in: PubMed
      5. Worley MJ, Tate S, Granholm E, Brown SA. Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression. J Consult Clin Psychol. 2014 Jun; 82(3):418-28. PMID: 24588403.
        View in: PubMed
      6. Worley MJ, Tate S, McQuaid JR, Granholm EL, Brown SA. 12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Subst Abus. 2013; 34(1):43-50. PMID: 23327503.
        View in: PubMed
      7. Tripp JC, Skidmore JR, Cui R, Tate S. Impact of Physical Health on Treatment for Co-occurring Depression and Substance Dependence. J Dual Diagn. 2013; 9(3). PMID: 24223036.
        View in: PubMed
      8. Worley MJ, Tate S, Brown SA. Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression. Addiction. 2012 Nov; 107(11):1974-83. PMID: 22578037.
        View in: PubMed
      9. Worley MJ, Trim RS, Roesch SC, Mrnak-Meyer J, Tate S, Brown SA. Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial. J Subst Abuse Treat. 2012 Oct; 43(3):291-302. PMID: 22406052.
        View in: PubMed
      10. Mrnak-Meyer J, Tate S, Tripp JC, Worley MJ, Jajodia A, McQuaid JR. Predictors of suicide-related hospitalization among U.S. veterans receiving treatment for comorbid depression and substance dependence: who is the riskiest of the risky? Suicide Life Threat Behav. 2011 Oct; 41(5):532-42. PMID: 21815915.
        View in: PubMed
      11. Tate S, Mrnak-Meyer J, Shriver CL, Atkinson JH, Robinson SK, Brown SA. Predictors of treatment retention for substance-dependent adults with co-occurring depression. Am J Addict. 2011 Jul-Aug; 20(4):357-65. PMID: 21679267.
        View in: PubMed
      12. Granholm E, Tate S, Link PC, Lydecker KP, Cummins KM, McQuaid J, Shriver C, Brown SA. Neuropsychological functioning and outcomes of treatment for co-occurring depression and substance use disorders. Am J Drug Alcohol Abuse. 2011 Jul; 37(4):240-9. PMID: 21517712.
        View in: PubMed
      13. Lydecker KP, Tate S, Cummins KM, McQuaid J, Granholm E, Brown SA. Clinical outcomes of an integrated treatment for depression and substance use disorders. Psychol Addict Behav. 2010 Sep; 24(3):453-65. PMID: 20853931.
        View in: PubMed
      14. Worley MJ, Trim RS, Tate S, Hall JE, Brown SA. Service utilization during and after outpatient treatment for comorbid substance use disorder and depression. J Subst Abuse Treat. 2010 Sep; 39(2):124-31. PMID: 20598832.
        View in: PubMed
      15. Norman SB, Tate S, Wilkins KC, Cummins K, Brown SA. Posttraumatic stress disorder's role in integrated substance dependence and depression treatment outcomes. J Subst Abuse Treat. 2010 Jun; 38(4):346-55. PMID: 20363091.
        View in: PubMed
      16. Drapkin ML, Tate S, McQuaid JR, Brown SA. Does initial treatment focus influence outcomes for depressed substance abusers? J Subst Abuse Treat. 2008 Oct; 35(3):343-50. PMID: 18295436.
        View in: PubMed
      17. Tate S, Wu J, McQuaid JR, Cummins K, Shriver C, Krenek M, Brown SA. Comorbidity of substance dependence and depression: role of life stress and self-efficacy in sustaining abstinence. Psychol Addict Behav. 2008 Mar; 22(1):47-57. PMID: 18298230.
        View in: PubMed
      18. Glasner-Edwards S, Tate S, McQuaid JR, Cummins K, Granholm E, Brown SA. Mechanisms of action in integrated cognitive-behavioral treatment versus twelve-step facilitation for substance-dependent adults with comorbid major depression. J Stud Alcohol Drugs. 2007 Sep; 68(5):663-72. PMID: 17690799.
        View in: PubMed
      19. Norman SB, Tate S, Anderson KG, Brown SA. Do trauma history and PTSD symptoms influence addiction relapse context? Drug Alcohol Depend. 2007 Sep 6; 90(1):89-96. PMID: 17459611.
        View in: PubMed
      20. Tate S, Norman SB, McQuaid JR, Brown SA. Health problems of substance-dependent veterans with and those without trauma history. J Subst Abuse Treat. 2007 Jul; 33(1):25-32. PMID: 17588486.
        View in: PubMed
      21. Brown SA, Glasner-Edwards SV, Tate S, McQuaid JR, Chalekian J, Granholm E. Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders. J Psychoactive Drugs. 2006 Dec; 38(4):449-60. PMID: 17373561.
        View in: PubMed
      22. Ramo DE, Anderson KG, Tate S, Brown SA. Characteristics of relapse to substance use in comorbid adolescents. Addict Behav. 2005 Oct; 30(9):1811-23. PMID: 16139961.
        View in: PubMed
      23. Tate S, McQuaid JR, Brown SA. Characteristics of life stressors predictive of substance treatment outcomes. J Subst Abuse Treat. 2005 Sep; 29(2):107-15. PMID: 16135339.
        View in: PubMed
      24. Tomlinson KL, Tate S, Anderson KG, McCarthy DM, Brown SA. An examination of self-medication and rebound effects: Psychiatric symptomatology before and after alcohol or drug relapse. Addict Behav. 2006 Mar; 31(3):461-74. PMID: 15972246.
        View in: PubMed
      25. Tate S, Brown SA, Unrod M, Ramo DE. Context of relapse for substance-dependent adults with and without comorbid psychiatric disorders. Addict Behav. 2004 Dec; 29(9):1707-24. PMID: 15530716.
        View in: PubMed
      26. Vik PW, Tate S, Carrello P. Detecting college binge drinkers using an extended time frame. Addict Behav. 2000 Jul-Aug; 25(4):607-12. PMID: 10972453.
        View in: PubMed
      27. Vik PW, Carrello P, Tate S, Field C. Progression of consequences among heavy-drinking college students. Psychol Addict Behav. 2000 Jun; 14(2):91-101. PMID: 10860108.
        View in: PubMed
      28. Brown SA, Tapert SF, Tate S, Abrantes AM. The role of alcohol in adolescent relapse and outcome. J Psychoactive Drugs. 2000 Jan-Mar; 32(1):107-15. PMID: 10801072.
        View in: PubMed
      29. Brown SA, Tate S, Vik PW, Haas AL, Aarons GA. Modeling of alcohol use mediates the effect of family history of alcoholism on adolescent alcohol expectancies. Exp Clin Psychopharmacol. 1999 Feb; 7(1):20-7. PMID: 10036606.
        View in: PubMed